Labcorp is a global leader in laboratory services, providing the insights and answers that help healthcare providers, patients, researchers, pharmaceutical companies and health systems make confident decisions and improve outcomes. Through our unparalleled science, data, technology and laboratory network, we advance diagnostics, accelerate innovation and help address some of the world’s most important health challenges. As we shape the future of healthcare, we are leveraging advanced technologies, intelligent digital solutions and data-driven innovation across our operations to enhance how work gets done and deliver greater value to customers and patients. With our global scale and deep expertise, you’ll have the opportunity to do meaningful work, grow your career and make a real impact on people’s health around the world. Together, we’re improving health and improving lives.
Labcorp is seeking a field-based Oncology Development Executive (Outside Sales) to join our team in theLaurinburg, NC territory
Responsibilities
Business Development & Territory Growth
Drive new business acquisition, competitive displacement, market penetration, and revenue growth across oncology practices, pathology groups, cancer centers, health systems, integrated delivery networks (IDNs), and academic medical centers.
Develop and execute territory growth strategies that increase adoption of Labcorp's oncology diagnostics, hereditary cancer, and precision medicine portfolio.
Achieve territory revenue, market share, new account, and growth objectives
Maintain accountability for opportunity management, pipeline development, forecasting accuracy, and sales performance through Salesforce CRM utilization
Strategic Account Management
Establish relationships with physician leaders, pathology groups, cancer center administrators, health system stakeholders, and executive decision makers.
Lead consultative sales engagements focused on oncology diagnostics, precision medicine adoption, operational efficiency, and testing strategy optimization.
Develop enterprise growth plans that expand utilization across health systems, cancer networks, and academic medical centers.
Influence testing pathways and adoption strategies within complex healthcare organizations.
Clinical & Scientific Expertise
Represent Labcorp's oncology diagnostics, hereditary cancer, molecular diagnostics, genomic profiling, liquid biopsy, ctDNA, MRD, biomarker, NGS-based testing, pathology, hematopathology, cytogenetics, FISH, flow cytometry, and virtual pathology solutions.
Translate clinical, genomic, and scientific evidence into business-focused recommendations that support customer decision making.
Maintain current knowledge of oncology diagnostics, hereditary cancer testing, molecular diagnostics, genomics, and precision medicine advancements.
Cross-Functional Leadership
Coordinate field sales, national accounts, pathology, medical affairs, market access, operations, and executive leadership resources to support growth initiatives.
Monitor competitive activity, market trends, and emerging oncology testing opportunities.
Travel up to 75% within the assigned territory.
Minimum Qualifications
High School Diploma with 9 years of relevant experience; or Associate degree with 7 years relevant experience; or Bachelor's degree with 5 years of relevant experience; or Master's degree with 3 years of relevant experience.
5 years of oncology sales, oncology diagnostics, molecular diagnostics, pharmaceutical oncology, biotechnology oncology, laboratory services, or precision medicine commercial experience
5 years of business development, territory management, or strategic account management experience
5 years of experience selling into oncology practices, pathology groups, cancer centers, health systems, IDNs, or academic medical centers.
Preferred Qualifications
Master's degree in Business Administration, Public Health, Life Sciences, Healthcare Administration, Pharmacy, or a scientific discipline
3years of oncology diagnostics, molecular diagnostics, genomics, hereditary cancer, precision medicine, companion diagnostics, liquid biopsy, or comprehensive genomic profiling experience.
3 years of experience commercializing NGS, molecular diagnostics, liquid biopsy, genomic profiling, hereditary cancer testing, pathology services, or precision medicine solutions.
3 years of experience supporting health systems, IDNs, academic medical centers, enterprise accounts, GPO contracting, RFP processes, or strategic account management.
3 years of experience selling pathology, hematopathology, cytogenetics, comprehensive genomic profiling, ctDNA, MRD, or biomarker testing solutions.
Additional Job Standards
Experience managing multi-stakeholder healthcare sales cycles involving clinical, operational, and executive decision makers.
Documented history of quota attainment, revenue growth, or new account acquisition.
Demonstrates effective written, verbal, and presentation communication skills.
Collaborates effectively with cross-functional and matrixed teams.
Demonstrates strong organizational skills and attention to detail.
Applies clinical and business knowledge to customer discussions and strategic planning.
Demonstrates adaptability, accountability, and results orientation in a dynamic healthcare environment.
Maintains knowledge of oncology care pathways, biomarker-driven testing, precision medicine initiatives, companion diagnostics, NCCN-guided testing strategies, and EHR/EMR connectivity considerations.
Develops productive relationships with oncologists, pathologists, cancer center leaders, genetics programs, and healthcare stakeholders.
Demonstrates consultative selling, influence, and relationship-building capabilities.
Experience utilizing Salesforce CRM for opportunity management, forecasting, pipeline management, and account planning.
Valid driver’s license and clean driving record
About the Role
The Oncology Development Executive (ODE) is a field-based business development professional responsible for driving new business acquisition, competitive displacement, and market share growth across oncology practices, health systems, academic medical centers, pathology groups, cancer centers, and genetics programs.
This role develops strategic partnerships and advances adoption of Labcorp's oncology diagnostics, hereditary cancer, and precision medicine solutions. The Oncology Development Executive serves as a trusted oncology resource, helping healthcare organizations implement testing strategies that support precision medicine initiatives and clinical decision making.
Why Labcorp Oncology?
At Labcorp Oncology, we are building a unified team with a shared purpose: advancing cancer care through innovation, collaboration, and an unwavering commitment to patients. We believe our greatest impact comes from combining the strengths of our people, science, and portfolio to help clinicians make informed decisions and improve outcomes across the cancer care continuum.
As an Oncology Development Executive, you will play a critical role in strengthening customer partnerships, expanding market adoption, supporting business growth, and advancing oncology initiatives across your territory. You will join a team that values accountability, ownership, collaboration, resilience, and a relentless focus on execution.
This is an opportunity to help shape the future of one of the industry's most comprehensive oncology organizations while working alongside talented colleagues united by a common mission: delivering innovative solutions that expand access, improve care, and create a better future for the patients and communities we serve.
Together, we are building One Labcorp Oncology: a high-performing team committed to growth, customer success, operational excellence, and advancing cancer care through every interaction.
Benefits: Employees regularly scheduled to work 20 or more hours per week are eligible for comprehensive benefits including: Medical, Dental, Vision, Life, STD/LTD, 401(k), Paid Time Off (PTO) or Flexible Time Off (FTO), Tuition Reimbursement and Employee Stock Purchase Plan. Employees regularly scheduled to work less than 20 hours, Casual, Intern, and Temporary employees are only eligible to participate in the 401(k) Plan. Employees who are regularly scheduled to work a 7 on/7 off schedule are eligible to receive all the foregoing benefits except PTO or FTO. For more detailed information, please click here
Labcorp is proud to be an Equal Opportunity Employer:
Labcorp strives for inclusion and belonging in the workforce and does not tolerate harassment or discrimination of any kind. We make employment decisions based on the needs of our business and the qualifications and merit of the individual. Qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex (including pregnancy, childbirth, or related medical conditions), family or parental status, marital, civil union or domestic partnership status, sexual orientation, gender identity, gender expression, personal appearance, age, veteran status, disability, genetic information, or any other legally protected characteristic. Additionally, all qualified applicants with arrest or conviction records will be considered for employment in accordance with applicable law.
We encourage all to apply
If you are an individual with a disability who needs assistance using our online tools to search and apply for jobs, or needs an accommodation, please visit our accessibility site or contact us at Labcorp Accessibility. For more information about how we collect and store your personal data, please see our Privacy Statement
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers.
As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities.
Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world.
Learn more about Labcorp (NYSE: LH) at www.labcorp.com.
